Abstract
Mycobacteriosis is an infectious disease caused by non-tuberculous mycobacteria (NTM), characterized by complicated verification, as it coincides in clinical, radiological and pathoanatomic characteristics with tuberculosis, the complexity of diagnosis and long-term treatment. It is known that many NTM are potential pathogens for humans, especially for individuals with impaired local or systemic immunity (HIV-infected people in paticular). However, studies have recently appeared aimed at establishing a specific genotype of the macroorganism and other genetic factors determining susceptibility to this infection. Patients do not pose an epidemiological danger and do not require isolation, since the possibility of transmission of NTM from person to person has not been proven, however, the answer to this question is still ambiguous. In this article we review and compare existing recommendations and guidelines on the management of patients with infections caused by the NTM (ATS/IDSA, CFF/ECFS, ATS/ERS/ESCMID/IDSA, draft recommendations of the Ministry of Health of the Russian Federation, HIV recommendations).
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow, Russia
-
1.
Zimina V.N., Degtyareva S.Yu., Beloborodova E.N., Kulabukhova E.I., Rusakova L.I., Fesenko O.V. Mycobacterioses: current state of the problem. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2017; 19(4):276-282. Russian.
-
2.
Metersky M.L., Fraulino D., Monday L., Chopra T. Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review. Postgrad Med. 2024;136(7):770-781.
DOI: 10.1080/00325481.2024.2401766
-
3.
Litvinov V.I. Nontuberculous mycobacteria in «inanimate and living nature», human infection. Tuberkulez i sotsial’no-znachimye zabolevaniya. 2015;(2):28-33. Russian.
-
4.
Lamy P., De Lavergne E., Dailloux M. Current aspects of lung infections with atypical mycobacteria. Ann Med Nancy. 1981;20(1):31-88.
-
5.
Tryland M., Olsen I., Vikøren T., Handeland K., Arnemo J.M., Tharaldsen J., et al. Serologic survey for antibodies against Mycobacterium avium subsp. paratuberculosis in free-ranging cervids from Norway. J Wildl Dis. 2004;40(1):32-41.
DOI: 10.7589/0090-3558-40.1.32
-
6.
Andréjak, C., Thomsen, V.Ø., Johansen, I. S., Riis, A., Benfield, T.L., Duhaut, P., et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181(5):514-521.
DOI: 10.1164/rccm.200905-0778OC
-
7.
Anisimova A., Pavlova M., Archakova L., Sapozhnikova N., Chernokhaeva I., Gavrilov P., et al. Mycobacteriosis of the lungs: difficulties of diagnosis and treatment (literature review). Medicinskij aljans. 2020;8(1):25-31. Russian.
DOI: 10.36422/23076348-2020-8-1-25-31
-
8.
Karpina N.L., Chashchina M.V., Egorova A.D., Smirnova T.G., Bagirov M.A., Ergeshov A.E. Etiological verification of pulmonary mycobacteriosis based on surgical material examination in patients diagnosed with A16.0 – real practice. Vestnik Central’nogo nauchnoissledovatel’skogo instituta tuberkuleza. 2023;7(4):46-56. Russian.
DOI: 10.57014/2587-6678-2023-7-4-46-56
-
9.
Masters T.L., Toney N.C., Ewing T.O., McAllister G.A., Mathis M.H., Grigg C., et al. Genomic epidemiology of extrapulmonary nontuberculous mycobacteria isolates at emerging infections program sites – United States, 2019-2020. J Infect Dis. 2025;231(4):902-912.
DOI: 10.1093/infdis/jiae488
-
10.
Chancharoenthana W., Kamolratanakul S., Rotcheewaphan S., Leelahavanichkul A., Schultz M.J. Recent advances in immunopathogenesis and clinical practice: mastering the challenge – managing of non-tuberculous mycobacteria. Front Immunol. 2025;16:1554544.
DOI: 10.3389/fimmu.2025.1554544
-
11.
Solomay T.V. Epidemiological features of mycobacterioses caused by nontuberculous mycobacteria. Sanitarnyj vrach. 2015;(3):30-36. Russian.
-
12.
Sanz Santaeufemia F.J., Ramos Amador J.T., Giangaspro E., Sánchez Granados J.M., Palenque E., González Tomé M.I. Usefulness of antibiotic therapy combined with surgery in the treatment of nontuberculous mycobacterial adenitis. An Pediatr (Barc). 2005;62(3):280-285.
DOI: 10.1157/13071845
-
13.
Abaleka F.I., Nigussie B., Onal O., Al-Zakhari R., Yimer E. A case of isolated pulmonary Mycobacterium avium complex being the first presentation of a newly diagnosed HIV/AIDS. Cureus. 2020;12(7):e9223.
DOI: 10.7759/cureus.9223
-
14.
Fazylov V.Kh., Petrov I.V., Petrova L.V., Petrova F.S., Amirova T.Kh. Problems of laboratory diagnosis and species identification of mycobacteria. Infektsionnye bolezni: novosti, mneniya, obuchenie. 2021;10(3):118-126. Russian.
DOI: 10.33029/2305-3496-2021-10-3-118-126
-
15.
Shmelev E.I., Kovalevskaya M.N., Ergeshov A.E., Chernousova L.N., Larionova E.E. Mycobacteriosis in the practice of a pulmonologist: current state of the problem. Prakticheskaya pul'monologiya. 2016;(3):37-42. Russian.
-
16.
Sokolina I.A. Imaging of pulmonary nontuberculous mycobacterial infection. Consilium Medicum. 2017; 19(3):24-28. Russian.
-
17.
Makarova M.V., Guntupova L.D. Non-tuberculous Mycobacteria. BIOpreparations. Prevention, Diagnosis, Treatment. 2020;20(2):97-102. Russian.
DOI: 10.30895/2221-996X2020-20-2-97-102
-
18.
Buckland M., Ali R., Bothamley G., Lammas D., Doffinger R., Longhurst H., et al. Recurrent mycobacterial infections in a patient with IL-12 deficiency. BMJ Case Rep. 2009;2009:bcr11.2008.1278.
DOI: 10.1136/bcr.11.2008.1278
-
19.
Chen Y., Miao Q., Bao R., Qu H., Shen J., Li N., et al. Distinct lung microbiota community states are associated with pulmonary nontuberculous mycobacterial disease prognosis. BMC Microbiol. 2025;25(1):653.
DOI: 10.1186/s12866-025-04420-7
-
20.
Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416.
DOI: 10.1164/rccm.200604-571ST
-
21.
Floto R.A., Olivier K.N., Saiman L., Daley C.L., Herrmann J.L., Nick J.A., et al.; US Cystic Fibrosis Foundation and European Cystic Fibrosis Society. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl. 1):i1-22.
DOI: 10.1136/thoraxjnl-2015-207360
-
22.
Lange C., Böttger E.C., Cambau E., Griffith D.E., Guglielmetti L., van Ingen J., et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis. 2022;22(7):e178-e190.
DOI: 10.1016/S1473-3099(21)00586-7
-
23.
Daley C.L., Iaccarino J.M., Lange C., Cambau E., Wallace R.J. Jr, Andrejak C., et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535.
DOI: 10.1183/13993003.00535-2020
-
24.
Clinical recommendations: Mycobacteriosis of the respiratory system, Draft recommendations of the Ministry of Health of the Russian Federation: not approved by the Ministry of Health. 2020. Available at: https://spulmo.ru/upload/kr/Microbakterioz_2022.pdf. Accessed November 14, 2025. Russian.
-
25.
Kaplan J.E., Benson C., Holmes K.K., Brooks J.T., Pau A., Masur H., et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207. PMID: 19357635.
-
26.
Woods G.L., Brown-Elliott B.A., Conville P.S., Desmond E.P., Hall G.S., Lin G., et al. Clinical and Laboratory Standards Institute (CLSI). Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard – Second Edition. CLSI document M24-A2 (ISBN 1-56238-746-4). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2011.
-
27.
Makaryants N.N., Karnaushkina M.A., Salamaikina S.A., Mironov K.O., Babak S.L., Strutynskaya A.D. Clinical case of progressive pulmonary mycobacteriosis potentially associated with genetic predisposition in a patient with mild bronchial asthma. Klinicheskiy razbor v obshchey meditsine. 2024;5(2):72-77. Russian.
DOI: 10.47407/kr2023.5.2.00391
-
28.
Borisova O.V., Mordyk A.V. Epidemiology, clinical manifestations, diagnosis, and treatment of mycobacterioses: a literature review. Medicinskij aljans. 2019;(2):35-45. Russian.